Of the dogs that were treated with resveratrol, 40% (2/6 dogs) developed stage-1 AKI (defined by an increment in SCr > 26.4 μmol/L) compared to 100% of the dogs in the control group, even though this difference did not reach statistical significance.
← all excerpts
Improved Cardiovascular Tolerance to Hemorrhage after Oral Resveratrol Pretreatment in Dogs.
1
—
—